Gamida Cell Competitors, Revenue and Alternatives
Estimated Revenue & Financials
- Gamida Cell's estimated annual revenue is currently $11.2M per year.
- Gamida Cell's estimated revenue per employee is $155,000
- Gamida Cell's total funding is $203.1M.
- Gamida Cell has 72 Employees.
- Gamida Cell grew their employee count by 1% last year.
- Gamida Cell currently has 3 job openings.
|Competitor Name||Revenue||Number of Employees||Employee Growth||Total Funding|
What Is Gamida Cell?
Gamida Cell is a leader in cellular and immune therapeutics, committed to changing the treatment paradigm for patients with cancer and rare genetic diseases. We are building a broad pipeline based on our proprietary NAM technology platform. Our lead program, NiCord, is in phase 3 development for allogeneic bone marrow transplantation and was granted Breakthrough Therapy Designation by the FDA.keywords:N/A
Number of Employees
Employee Growth %
|Lindsay Luke||VP, Professional Alliances|
|Jaren Madden||Vice President, Investor Relations and Corporate Communications||Email Available|
|Paul Nee||Vice President Marketing||Email Available|
|Josh Hamermesh||Chief Business Officer||Email Available|
|John Uhrin||Sr Director , Customer Experience & Patient Services|
|Ronit Simantov||Chief Medical Officer||Email Available|
|Chad Boily||Study Logistics Manager|
|Debbie Chirnomas||VP, Clinical Development and Medical Affairs|
|Zelda Wildman||Medical Manager|
|Tracey Lodie||Chief Scientific Officer|
Gamida Cell News
Gamida Cell Ltd. GMDA has been on a bit of a cold streak lately, but there might be light at the end of the tunnel for this overlooked stock.
Every investor in Gamida Cell Ltd. (NASDAQ:GMDA) should be aware of the most powerful shareholder groups. Insiders often own a large ...
Gamida Cell Ltd. (NASDAQ:GMDA) Q2 2019 Earnings Conference Call August 6, 2019 8:30 AM ET. Company Participants. Julian Adams - ...